Bibliographic Details
| Title: |
Corrigendum: Anticancer effects of ABTL0812, a clinical stage drug inducer of autophagy-mediated cancer cell death, in glioblastoma models. |
| Authors: |
Mancini, Andrea, Colapietro, Alessandro, Cristiano, Loredana, Rossetti, Alessandra, Mattei, Vincenzo, Gravina, Giovanni Luca, Perez-Montoyo, Héctor, Yeste-Velasco, Marc, Alfon, Jose, Domenech, Carles, Festuccia, Claudio |
| Source: |
Frontiers in Oncology; 2025, p1-3, 3p |
| Subject Terms: |
ORAL drug administration, CELL nuclei, TUMOR growth, GLIOBLASTOMA multiforme, TUBULINS, EVEROLIMUS |
| Abstract: |
The correction notice in the journal "Frontiers in Oncology" addresses errors in the cropping and placement of images in the article "Anticancer effects of ABTL0812 in glioblastoma models." The authors have rectified these mistakes in Figures 2 and 6 by replacing incorrect images with the correct ones. The corrections do not alter the scientific conclusions of the original article. The study highlights the potential of ABTL0812 in inducing cancer cell death and impairing tumor growth in glioblastoma models. [Extracted from the article] |
|
Copyright of Frontiers in Oncology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
